Real-time enrollment status for this triple negative breast cancer (tnbc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:12 PM UTC
| NCT Number | NCT07652242 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer (TNBC) |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Immunomic Therapeutics, Inc. |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07652242 is currently recruiting participants. This clinical trial study for triple negative breast cancer (tnbc) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Immunomic Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07652242 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07652242 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.